Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent subjects

Jenny Ceccarini, Gil Leurquin-Sterk, Cleo Crunelle, Bart De Laat, Guy Bormans, Hendrik Peuskens and Koen Van Laere
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 14;
Jenny Ceccarini
3University Hospitals Leuven - KU Leuven Leuven Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gil Leurquin-Sterk
4Nuclear Medicine and Molecular Imaging University Hospitals Leuven - KU Leuven Leuven Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cleo Crunelle
5Toxicological Center University of Antwerp Wilrijk Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart De Laat
2MoSAIC, Molecular Small Animal Imaging Center KU Leuven Leuven Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Bormans
1Laboratory for Radiopharmacy K.U. Leuven Leuven Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Peuskens
6UPC KU Leuven Leuven Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koen Van Laere
4Nuclear Medicine and Molecular Imaging University Hospitals Leuven - KU Leuven Leuven Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

14

Objectives: Animal models of alcohol dependence have demonstrated a central role of cerebral metabotropic glutamate receptor 5 (mGluR5) in relapse behaviors. Using [18F]FPEB positron emission tomography, it was found that chronic alcohol use lead to decreased limbic mGluR5 availability compared to healthy controls, where lower mGluR5 was associated with less craving. Here, we tested whether the state of decreased mGluR5 availability in the same alcohol-dependent subjects normalizes during longer-term (6 months) abstinence and whether initial mGluR5 imaging parameters can predict relapse.

Methods: Dynamic 90 minute [18F]FPEB scans combined with arterial blood sampling were performed in healthy controls (n = 32) and in alcohol-dependent patients (n = 16) within the 2 first weeks of medically supervised abstinence (i.e., the baseline condition), and after 2 months (n = 10) and 6 months (n = 8) following a alcohol detoxification program after baseline. Craving at these follow-up moments was assessed using the Desire for Alcohol Questionnaire (DAQ), a validated tool measuring three facets of craving. Alcohol consumption was assessed subjectively by a Time-Line Follow Back for the entire follow-up period and serial quantitative hair ethyl glucuronide analysis. Regional mGluR5 availability was quantified in controls and at each time point in patients by the [18F]FPEB total distribution volume [Leurquin-Sterk et al. Synapse 2016], corrected for partial volume effect, and analyzed using both a voxel-by-voxel and a volume-of-interest analysis.

Results: During abstinence, alcohol-dependent subjects showed gradual increases in mGluR5 availability in cortical and subcortical brain areas (pheight < 0.001, t statistic > 5.7) compared to baseline, up to the levels observed in healthy controls after 6 months (see Figure A), except in the hippocampus, nucleus accumbens and thalamus that had not recovered fully. A higher striatal mGluR5 availability at baseline was observed in patients who relapsed during the 6-month follow-up period compared to abstainers (+25.1%, pheight = 0.003 at x=-22; y=-10; z=-2) (see Figure B). Also, better recovery of mGluR5 in the striatum was associated with higher reduction in two different aspects of craving (i.e., Desire and intention to drink and Negative reinforcement; r > 0.72, p range = 0.001 - 0.045).

Conclusion: This study provides the first evidence that reduced cerebral mGluR5 availability in alcohol-dependent subjects recovers during abstinence, linked to reduction in craving behaviors. Higher striatal mGluR5 availability at the start of detoxification may be a predictive marker for long-term relapse. Research Support: Jenny Ceccarini is a postdoctoral fellow of the Research Foundation - Flanders (FWO). Koen Van Laere is senior clinical research fellow for the FWO and has received an FWO research grant for this work (FWO/G.0548.06).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent subjects
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent subjects
Jenny Ceccarini, Gil Leurquin-Sterk, Cleo Crunelle, Bart De Laat, Guy Bormans, Hendrik Peuskens, Koen Van Laere
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 14;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent subjects
Jenny Ceccarini, Gil Leurquin-Sterk, Cleo Crunelle, Bart De Laat, Guy Bormans, Hendrik Peuskens, Koen Van Laere
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 14;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

Brain Imaging Council Young Investigator Award Symposium

  • Assessment of potential protective effect on dopaminergic neuron by an Fas-associated factor 1 inhibitor treatment using [18F]FE-PE2I PET in a Parkinson’s disease mouse model
  • Contribution of simultaneous PET-MRI to understanding the neuropharmacology of 5-HT1A receptor biased agonists.
  • Potential effect of a fluorine position in the aromatic molecule (CP-118,954) on the neuropharmacological property and PET imaging quantification for AChE expression
Show more Brain Imaging Council Young Investigator Award Symposium

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire